Virtus ETF Advisers LLC Day One Biopharmaceuticals, Inc. Transaction History
Virtus ETF Advisers LLC
- $234 Million
- Q4 2024
A detailed history of Virtus ETF Advisers LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 27,296 shares of DAWN stock, worth $334,648. This represents 0.15% of its overall portfolio holdings.
Number of Shares
27,296
Previous 25,491
7.08%
Holding current value
$334,648
Previous $355,000
2.82%
% of portfolio
0.15%
Previous 0.17%
Shares
12 transactions
Others Institutions Holding DAWN
# of Institutions
181Shares Held
79.7MCall Options Held
130KPut Options Held
217K-
Atlas Venture Life Science Advisors, LLC6.43MShares$78.8 Million13.44% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.85MShares$71.7 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$70.6 Million1.18% of portfolio
-
Braidwell LP Stamford, CT4.87MShares$59.8 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$55.6 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $901M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...